![](/img/cover-not-exists.png)
A Phase II Study of Capecitabine, Oxaliplatin, and Bevacizumab in the Treatment of Metastatic Esophagogastric Adenocarcinomas
Uronis, H. E., Bendell, J. C., Altomare, I., Blobe, G. C., Hsu, S. D., Morse, M. A., Pang, H., Zafar, S. Y., Conkling, P., Favaro, J., Arrowood, C. C., Cushman, S. M., Meadows, K. L., Brady, J. C., NiVolume:
18
Language:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2012-0404
Date:
March, 2013
File:
PDF, 121 KB
english, 2013